NCT04258865View on ClinicalTrials.gov

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

April 26, 2020

Study Completion Date

May 13, 2020

Conditions
HypertensionDyslipidemias
Interventions
DRUG

CKD-348 F1

QD, PO

DRUG

CKD-348 F2

QD, PO

DRUG

CKD-828, D097, D337

QD, PO

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04258865 - A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 | Biotech Hunter | Biotech Hunter